Myeloprotection with activated carbon in doxorubicin-treated rats

Myeloprotection with activated carbon in doxorubicin-treated rats

Chemotherapy can often cause a variety of side effects including bone marrow (BM) suppression, termed as myelosuppression. Accordingly, facile and effective management of chemotherapy-induced myelosuppression is currently a pivotal task for experimental pathologists and oncologists. Here, we chose t...

Full description

Bibliographic Details
Main Authors: Bogdan I. Gerashchenko, Veronika V. Sarnatskaya, Kvitoslava I. Bardakhivska, Oleksii S. Sydorenko, Denis L. Kolesnik, Dmytro O. Klymchuk
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:Heliyon
Subjects:
Doxorubicin
Activated carbon
Bone marrow
Hematopoiesis
Myeloprotection
Total nucleated cells
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023056220

Internet

http://www.sciencedirect.com/science/article/pii/S2405844023056220

Similar Items